Plain-English translation of NCT07315347 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This research trial is testing whether cancer patients with acute pulmonary embolism—a blood clot in the lungs—can be safely cared for at home rather than staying in the hospital. Researchers want to understand if home treatment is as safe as hospitalization for certain cancer patients whose condition is stable and meets specific safety criteria. If home treatment proves safe, it could let patients stay in their own environment while recovering.
Cancer patients who develop blood clots in their lungs often face hospitalization, which can be long and disruptive to their lives. Recent research suggests that some of these patients—particularly those whose condition is stable—might do just as well at home with proper monitoring. This trial exists to confirm whether home treatment is truly safe for this group and to give cancer patients more choices about where they receive care.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to either home treatment or hospital treatment. If assigned to home treatment, you will be discharged within 24 hours after enrollment and monitored from home with blood thinner medication and follow-up appointments. If assigned to hospital treatment, you will stay in the hospital for at least 48 hours, after which doctors can decide whether to discharge you. Either way, you will be monitored closely for 30 days with follow-up visits to check for any complications.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
France